Arcturus Therapeutics Holdings Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ARCT research report →
About the company
Arcturus Therapeutics Holdings Inc. is a biotechnology company focused on RNA-based medicines, developing a pipeline of vaccines for infectious diseases alongside treatments for rare liver and respiratory conditions across the United States. Its notable development programs encompass LUNAR-OTC, designed for ornithine transcarbamylase (OTC) deficiency, and LUNAR-CF, targeting cystic fibrosis lung disease caused by specific CFTR gene mutations.
- CEO
- Joseph E. Payne
- IPO
- 2013
- Employees
- 174
- HQ
- San Diego, CA, US
Price Chart
- Market Cap
- $206.92M
- P/E
- -2.63
- P/S
- 4.56
- P/B
- 1.08
- EV/EBITDA
- -0.29
- Div Yield
- 0.00%
- Gross Margin
- 91.18%
- Op Margin
- -196.72%
- Net Margin
- -173.47%
- ROE
- -36.55%
- ROIC
- -41.43%
- Revenue
- $67.22M · -51.43%
- Net Income
- $-65,783,000 · 18.73%
- EPS
- $-2.40 · 20.00%
- Op Income
- $-74,955,000
- FCF YoY
- -22.98%
- 52W High
- $24.17
- 52W Low
- $5.85
- 50D MA
- $7.68
- 200D MA
- $9.28
- Beta
- 2.36
- Avg Volume
- 433.19K
Get TickerSpark's AI analysis on ARCT
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 5, 26 | HOLMES EDWARD W | other | 15,000 |
| Jun 5, 26 | FARRELL PETER C | other | 15,000 |
| Jun 5, 26 | BARLOW JAMES F | other | 15,000 |
| Jun 5, 26 | Markels John | other | 15,000 |
| Jun 5, 26 | Slaoui Moncef | other | 15,000 |
| Jun 5, 26 | Marquet Magda | other | 15,000 |
| Jun 5, 26 | Marantz Jing L. | other | 15,000 |
| May 1, 26 | MULROY DENNIS | other | 100,000 |
| May 1, 26 | MULROY DENNIS | other | 0 |
| Dec 17, 25 | Roberts Joseph | other | 10,000 |
Our ARCT coverage
Recent articles, reports, and earnings notes.
Want a deeper read on ARCT?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
Similar companies
Peers in the same neighborhood.